Bio Key International Stock Today

BKYI Stock  USD 1.65  0.10  5.71%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 84

 
High
 
Low
Very High
BIO Key is trading at 1.65 as of the 1st of May 2024. This is a -5.71 percent decrease since the beginning of the trading day. The stock's open price was 1.75. BIO Key has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for BIO Key International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of April 2024 and ending today, the 1st of May 2024. Click here to learn more.
Business Domain
Software & Services
IPO Date
14th of February 1997
Category
Industrials
Classification
Information Technology
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company has 1.81 M outstanding shares of which 8.74 K shares are currently shorted by private and institutional investors with about 0.35 trading days to cover. More on BIO Key International
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

BIO Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BIO Key's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BIO Key or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
MD ViceChairmanKwok Wong
Business ConcentrationSystems Software, Security & Protection Services, Information Technology, NASDAQ Composite, Information Technology, Software, Security & Protection Services, Industrials (View all Sectors)
Average Analyst Recommendation
Analysts covering BIO Key report their recommendations after researching BIO Key's financial statements, talking to executives and customers, or listening in on BIO Key's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering BIO Key International. The BIO consensus assessment is calculated by taking the average forecast from all of the analysts covering BIO Key.
Financial Strength
Based on the key measurements obtained from BIO Key's financial statements, BIO Key International is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in June. Financial strength of BIO Key International is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.580.53
Significantly Up
Slightly volatile
Total Current Liabilities3.1 M4.2 M
Way Down
Slightly volatile
Total Assets10.2 M13.7 M
Way Down
Slightly volatile
Total Current Assets11.3 M10.8 M
Sufficiently Up
Slightly volatile
BIO Key's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to BIO Key's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BIO Key's financial leverage. It provides some insight into what part of BIO Key's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on BIO Key's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how BIO Key deploys its capital and how much of that capital is borrowed.
Liquidity
BIO Key cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 2.22 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. BIO Key International has a current ratio of 3.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist BIO Key until it has trouble settling it off, either with new capital or with free cash flow. So, BIO Key's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BIO Key International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BIO to invest in growth at high rates of return. When we think about BIO Key's use of debt, we should always consider it together with cash and equity.

Change In Working Capital

(555,047)
BIO Key International (BKYI) is traded on NASDAQ Exchange in USA. It is located in Building A, Wall, NJ, United States, 07719 and employs 51 people. BIO Key is listed under Systems Software category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BIO Key's market, we take the total number of its shares issued and multiply it by BIO Key's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BIO Key International conducts business under Software sector and is part of Information Technology industry. The entity has 1.81 M outstanding shares of which 8.74 K shares are currently shorted by private and institutional investors with about 0.35 trading days to cover. BIO Key International currently holds about 4.89 M in cash with (4.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Check BIO Key Probability Of Bankruptcy
Ownership Allocation
BIO Key International shows 4.9 percent of its outstanding shares held by insiders and 5.4 percent owned by other corporate entities.
Check BIO Ownership Details

BIO Stock Price Odds Analysis

Coming from a normal probability distribution, the odds of BIO Key jumping above the current price in 90 days from now is roughly 96.0%. The BIO Key International probability density function shows the probability of BIO Key stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days BIO Key International has a beta of -0.8473 suggesting as returns on the benchmark increase, returns on holding BIO Key are expected to decrease at a much lower rate. During a bear market, however, BIO Key International is likely to outperform the market. Additionally, bIO Key International has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 1.65HorizonTargetOdds Above 1.65
3.56%90 days
 1.65 
96.41%
Based on a normal probability distribution, the odds of BIO Key to move above the current price in 90 days from now is roughly 96.0 (This BIO Key International probability density function shows the probability of BIO Stock to fall within a particular range of prices over 90 days) .

BIO Stock Institutional Holders

Institutional Holdings refers to the ownership stake in BIO Key that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BIO Key's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BIO Key's value.
InstituionRecorded OnShares
Renaissance Technologies Corp2023-12-31
0.0
Vanguard Group Inc2023-12-31
0.0
Geode Capital Management, Llc2023-12-31
0.0
Jpmorgan Chase & Co2023-12-31
0.0
Armistice Capital, Llc2023-12-31
65.3 K
Citadel Advisors Llc2023-09-30
21.3 K
Tower Research Capital Llc2023-12-31
6.2 K
Advisor Group Holdings, Inc.2023-12-31
1000
Group One Trading, Lp2023-12-31
334
Abich Financial Wealth Management Llc2023-12-31
37.0
Wells Fargo & Co2023-12-31
9.0
View BIO Key Diagnostics

BIO Key Historical Income Statement

BIO Key International Income Statement is one of the three primary financial statements used for reporting BIO's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of BIO Key International revenue and expense. BIO Key Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, BIO Key's Tax Provision is increasing as compared to previous years. The BIO Key's current Reconciled Depreciation is estimated to increase to about 712.4 K, while Depreciation And Amortization is forecasted to increase to (5.9 M). View More Fundamentals

BIO Stock Against Markets

Picking the right benchmark for BIO Key stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BIO Key stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BIO Key is critical whether you are bullish or bearish towards BIO Key International at a given time. Please also check how BIO Key's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in BIO Key without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module

BIO Key Corporate Directors

BIO Key corporate directors refer to members of a BIO Key board of directors. The board of directors generally takes responsibility for the BIO Key's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BIO Key's board members must vote for the resolution. The BIO Key board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

How to buy BIO Stock?

Before investing in BIO Key, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in BIO Key. To buy BIO Key stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of BIO Key. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase BIO Key stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located BIO Key International stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased BIO Key International stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as BIO Key International, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy BIO Stock please use our How to Invest in BIO Key guide.

Already Invested in BIO Key International?

The danger of trading BIO Key International is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BIO Key is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BIO Key. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BIO Key International is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for BIO Stock analysis

When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stocks Directory
Find actively traded stocks across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is BIO Key's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.62)
Revenue Per Share
17.484
Quarterly Revenue Growth
0.323
Return On Assets
(0.27)
Return On Equity
(1.26)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.